News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

GeoPharma, Inc. (GORX) Retains The Anne McBride Company Inc. As Investor Relations Counsel

10/19/2005 5:12:25 PM

LARGO, Fla., Dec. 8 /PRNewswire-FirstCall/ -- GeoPharma Inc. today announced that it has retained The Anne McBride Company Inc. (AMcB), a full-service financial communications and strategic consulting firm based in New York, to provide strategic investor relations counsel.

In this capacity, The Anne McBride Company will be responsible for managing GeoPharma's relations with the investment community by promoting awareness of GeoPharma's financial performance and strategic objectives.

GeoPharma's Chief Executive Officer, Mihir Taneja said, "The appointment of The Anne McBride Company reflects GeoPharma's desire to proactively communicate with its current and future shareholders. We selected The Anne McBride Company based on its reputation and proven track record of adding value and developing relationships with the investment community and financial media. Through the agency's expertise, knowledge base and understanding of the healthcare industry, we are confident that we can enhance shareholder value and solidify our position as an emerging leader in the manufacturing and distribution of specialty pharmaceuticals, generics and nutritional products."

"AMcB is excited to be working with GeoPharma to increase the company's exposure within the financial community, and key constituents within the healthcare sector. With GeoPharma's recent FDA approval of Mucotrol(TM), a medical device for the management of pain associated with mucositis that may develop from radiation and/or chemo therapy, we believe GeoPharma is well- positioned to compete," stated Anne McBride, Chairman and CEO of The Anne McBride Company. "We look forward to working with the GeoPharma management team in developing a strategic communications program that effectively communicates the Company's business strategy and growth opportunities to the investment community and the financial media."

GeoPharma, Inc. manufactures, packages, repackages and distributes a wide array of health-related products. GeoPharma, Inc.'s wholly-owned subsidiary, Belcher Pharmaceuticals is an FDA registered plant that manufactures and distributes over-the-counter and generic drugs. For more about GeoPharma, Inc. go to our website at

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries' expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company's management as of the date hereof, and actual results may vary based upon future events, both within and without management's control. Important factors that could cause such differences are described in the company's periodic filings with the Securities and Exchange Commission.

CONTACT INFORMATION: GeoPharma: Carol Dore-Falcone, VP/CFO, Tel: 727-544-8866 x244, E: Investor Relations: Rachel Levine, The Anne McBride Company, Tel: 212-983-1702 x207, E: Media Relations: Ivette Almeida, The Anne McBride Company, Tel: 212-983-1702 x209, E:

GeoPharma Inc.

CONTACT: GeoPharma - Carol Dore-Falcone, VP/CFO, +1-727-544-8866,ext. 244,; or Investor Relations - Rachel Levine,+1-212-983-1702, ext. 207,, or Media Relations -Ivette Almeida, +1-212-983-1702, ext. 209,,both of The Anne McBride Company, for GeoPharma Inc.

Read at

comments powered by Disqus